Literature DB >> 16459279

Pain behaviors produced by capsaicin: influence of inflammatory mediators and nerve injury.

Jana Sawynok1, Allison Reid, Jason Meisner.   

Abstract

UNLABELLED: The present study was undertaken to characterize spontaneous (ie, nonevoked) pain behaviors (flinching, biting/licking) produced by local injections of capsaicin into the rat hindpaw as a model of chemogenic pain, and to determine effects of inflammatory mediators and nerve injury on such behaviors. Capsaicin antagonists are a potential class of novel topical analgesics, and this model may be of value for preclinical screening of novel compounds. Local injections of capsaicin (0.1-30 microg) into the hindpaw produced flinching and biting/licking behaviors over 5 min, and these were reduced by capsazepine, a competitive antagonist for capsaicin at the TRPV1 receptor. Coadministration of noradrenaline (NA), prostaglandin E(2) (PGE(2)), and 5-hydroxytryptamine (5-HT) augmented capsaicin-evoked responses primarily by extending the duration of behaviors. Partial sciatic nerve ligation decreased flinching produced by capsaicin alone, by capsaicin in combination with each of NA, PGE(2), and 5-HT, and by formalin. Tibial nerve injury also reduced capsaicin-evoked flinching, and responses to formalin, but spinal nerve ligation did not affect either. These results indicate that (1) spontaneous pain behaviors occur as a result of TRPV1 receptor activation with a different time course than evoked responses, (2) inflammatory mediators augment capsaicin-evoked pain behaviors, and (3) various forms of nerve injury produce different effects on capsaicin-evoked pain behaviors. PERSPECTIVE: The VR1 receptor is a potential target for development of novel topical analgesics. This study characterized pain behaviors produced by local injections of capsaicin in the presence of inflammatory mediators and following various forms of nerve injury. Results are of interest for the preclinical screening of novel VR1 receptor antagonists.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16459279     DOI: 10.1016/j.jpain.2005.09.013

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  9 in total

Review 1.  TRPV1: on the road to pain relief.

Authors:  Andrés Jara-Oseguera; Sidney A Simon; Tamara Rosenbaum
Journal:  Curr Mol Pharmacol       Date:  2008-11       Impact factor: 3.339

2.  Activation of spinal mu- and delta-opioid receptors potently inhibits substance P release induced by peripheral noxious stimuli.

Authors:  Hélène Beaudry; Dave Dubois; Louis Gendron
Journal:  J Neurosci       Date:  2011-09-14       Impact factor: 6.167

Review 3.  Predictive validity of behavioural animal models for chronic pain.

Authors:  Odd-Geir Berge
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

4.  The anti-inflamatory effect of Andira anthelmia lectin in rats involves inhibition of the prostanoid pathway, TNF-α and lectin domain.

Authors:  Francisco Lucas Faustino do Nascimento; Alana de Freitas Pires; Mário Rogério Lima Mota; Pedro Henrique Chaves Isaias; Diego Freitas de Araujo; Maria Gleiciane de Queiroz Martins; Cleane Gomes Moreira; João Batista Cajazeiras; Benildo Sousa Cavada; Kyria Santiago do Nascimento; Ana Maria Sampaio Assreuy
Journal:  Mol Biol Rep       Date:  2022-07-26       Impact factor: 2.742

5.  Repeated administration of mazindol reduces spontaneous pain-related behaviors without modifying bone density and microarchitecture in a mouse model of complete Freund's adjuvant-induced knee arthritis.

Authors:  L E Robledo-González; A Martínez-Martínez; V M Vargas-Muñoz; R I Acosta-González; R Plancarte-Sánchez; M Anaya-Reyes; C Fernández Del Valle-Laisequilla; J G Reyes-García; J M Jiménez-Andrade
Journal:  J Pain Res       Date:  2017-07-27       Impact factor: 3.133

6.  Inhibition of transient receptor potential vanilloid type 1 through α2 adrenergic receptors at peripheral nerve terminals relieves pain.

Authors:  Yumi Matsushita; Miki Manabe; Issei Kitagawa; Masashi Higuchi; Yoshinao Z Hosaka; Naoki Kitamura
Journal:  J Vet Med Sci       Date:  2021-09-01       Impact factor: 1.267

7.  Electroacupuncture inhibits the interaction between peripheral TRPV1 and P2X3 in rats with different pathological pain.

Authors:  Yingjun Liu; Junying Du; Junfan Fang; Xuaner Xiang; Yingling Xu; Sisi Wang; Haiju Sun; Jianqiao Fang
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

8.  Selective cold pain inhibition by targeted block of TRPM8-expressing neurons with quaternary lidocaine derivative QX-314.

Authors:  Serra Ongun; Angela Sarkisian; David D McKemy
Journal:  Commun Biol       Date:  2018-05-31

9.  TRPV1 Channel Activated by the PGE2/EP4 Pathway Mediates Spinal Hypersensitivity in a Mouse Model of Vertebral Endplate Degeneration.

Authors:  Sijing Liu; Qiong Wang; Ziyi Li; Lei Ma; Ting Li; Yukun Li; Na Wang; Chang Liu; Peng Xue; Chuan Wang
Journal:  Oxid Med Cell Longev       Date:  2021-08-21       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.